Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at AOS's multiple
$1.1271.8% below market
0.94 ZNTL revenue / share×1.20x AOS P/S=$1.12
Market $3.99Implied $1.12
AOS · current priceP/S 1.20x
$60.48Latest market snapshot
Implied fair value · at ZNTL's multiple
$115.1990.5% above market
27.16 AOS revenue / share×4.24x ZNTL P/S=$115.19
Market $60.48Implied $115.19